Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$32.18 - $46.57 $1,544 - $2,235
-48 Reduced 0.53%
8,958 $402,000
Q3 2023

Nov 14, 2023

SELL
$44.2 - $50.2 $80,002 - $90,862
-1,810 Reduced 16.73%
9,006 $410,000
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $18,765 - $39,616
589 Added 5.76%
10,816 $468,000
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $15,767 - $25,768
347 Added 3.51%
10,227 $672,000
Q4 2022

Feb 15, 2023

BUY
$41.39 - $81.0 $71,232 - $139,401
1,721 Added 21.09%
9,880 $444,000
Q3 2022

Nov 16, 2022

BUY
$72.36 - $113.1 $7,670 - $11,988
106 Added 1.32%
8,159 $590,000
Q2 2022

Aug 23, 2022

SELL
$87.2 - $114.05 $82,927 - $108,461
-951 Reduced 10.56%
8,053 $864,000
Q2 2022

Aug 16, 2022

BUY
$87.2 - $114.05 $122,690 - $160,468
1,407 Added 18.52%
9,004 $966,000
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $70,265 - $92,869
746 Added 10.89%
7,597 $843,000
Q4 2021

Feb 14, 2022

SELL
$119.57 - $139.07 $38,979 - $45,336
-326 Reduced 4.54%
6,851 $877,000
Q3 2021

Nov 16, 2021

BUY
$109.17 - $142.35 $2,947 - $3,843
27 Added 0.38%
7,177 $955,000
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $199,174 - $229,644
1,985 Added 38.43%
7,150 $773,000
Q1 2021

May 17, 2021

BUY
$101.51 - $125.27 $204,136 - $251,917
2,011 Added 63.76%
5,165 $544,000
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $31,002 - $38,034
-361 Reduced 10.27%
3,154 $328,000
Q3 2020

Nov 17, 2020

BUY
$72.74 - $92.5 $23,276 - $29,600
320 Added 10.02%
3,515 $303,000
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $5,666 - $9,326
-118 Reduced 3.56%
3,195 $234,000
Q1 2020

May 15, 2020

BUY
$36.95 - $62.95 $122,415 - $208,553
3,313 New
3,313 $159,000
Q4 2019

Feb 14, 2020

SELL
$47.06 - $56.64 $123,861 - $149,076
-2,632 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$47.45 - $58.05 $93,002 - $113,778
-1,960 Reduced 42.68%
2,632 $125,000
Q2 2019

Aug 13, 2019

SELL
$39.26 - $54.21 $1,413 - $1,951
-36 Reduced 0.78%
4,592 $249,000
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $32,137 - $47,301
1,077 Added 30.33%
4,628 $188,000
Q4 2018

Feb 13, 2019

BUY
$29.95 - $46.34 $3,324 - $5,143
111 Added 3.23%
3,551 $111,000
Q3 2018

Nov 15, 2018

BUY
$40.12 - $45.55 $23,229 - $26,373
579 Added 20.24%
3,440 $157,000
Q2 2018

Aug 13, 2018

SELL
$38.72 - $42.52 $4,530 - $4,974
-117 Reduced 3.93%
2,861 $120,000
Q1 2018

May 15, 2018

BUY
$39.4 - $47.39 $36,405 - $43,788
924 Added 44.99%
2,978 $117,000
Q4 2017

Feb 14, 2018

BUY
$37.27 - $43.02 $76,552 - $88,363
2,054
2,054 $84,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.